Figure 1.
Figure 1. Estimation of DC numbers in blood and assessment of the purity of isolated pcDCs and myDCs. DCs were identified in peripheral blood mononuclear cells by their lack of labeling for a cocktail of CD3, CD14, CD16, and CD19, but positive labeling for HLA-DR (panel Ai; R2). The DCs were subsequently separated into 2 populations on the basis of labeling for CD11c (panel Aii). Following isolation with BDCA-1 and BDCA-4, the plasmacytoid (panel B) and myeloid (panel C) DCs were highly purified. Contaminating T lymphocytes are located in the upper left quadrant. For all infection studies, only DC preparations that contained fewer than 1% contaminating T lymphocytes were used. For functional studies, the majority of DC preparations had less than 1% contaminating T lymphocytes; however, 3 myDC and 3 pcDC preparations had 1% to 5% contaminating T lymphocytes. The percentage of cells within each quadrant is shown.

Estimation of DC numbers in blood and assessment of the purity of isolated pcDCs and myDCs. DCs were identified in peripheral blood mononuclear cells by their lack of labeling for a cocktail of CD3, CD14, CD16, and CD19, but positive labeling for HLA-DR (panel Ai; R2). The DCs were subsequently separated into 2 populations on the basis of labeling for CD11c (panel Aii). Following isolation with BDCA-1 and BDCA-4, the plasmacytoid (panel B) and myeloid (panel C) DCs were highly purified. Contaminating T lymphocytes are located in the upper left quadrant. For all infection studies, only DC preparations that contained fewer than 1% contaminating T lymphocytes were used. For functional studies, the majority of DC preparations had less than 1% contaminating T lymphocytes; however, 3 myDC and 3 pcDC preparations had 1% to 5% contaminating T lymphocytes. The percentage of cells within each quadrant is shown.

Close Modal

or Create an Account

Close Modal
Close Modal